Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adm Tronics Unlimited Inc (OP: ADMT )

0.0724 +0.0056 (+8.38%)
Streaming Delayed Price Updated: 9:34 AM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 54,032
Open 0.0725
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0668
Today's Range 0.0631 - 0.0725
52wk Range 0.0592 - 0.1500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ADM Tronics Reports Fiscal Year 2024
Via ACCESSWIRE
ADM Tronics Shareholder Video Conference Replay Available Now for Viewing Online with Update on Vet-Sonotron Veterinary Pain Treatment Technology
Via ACCESSWIRE

Performance

YTD
-17.35%
-17.35%
1 Month
+3.13%
+3.13%
3 Month
-9.50%
-9.50%
6 Month
-30.72%
-30.72%
1 Year
-51.67%
-51.67%

More News

Read More
ADM Tronics to Host Shareholder Video Call on March 27 to Update Launch and Significance of Vet-Sonotron Veterinary Pain Treatment Device
Via ACCESSWIRE
ADM Tronics CEO Presents Vet-Sonotron Veterinary Therapy Device at Medical Device Industry Webinar
Via ACCESSWIRE
ADM Tronics’ Vet-Sonotron(R) Veterinary Pain Treatment Device Now in Production and Already Receiving Pre-Orders
Via ACCESSWIRE
ADM Tronics Reports First Quarter of Fiscal Year 2024 Results
Via ACCESSWIRE
ADM Tronics Reports Fiscal Year 2023
Via ACCESSWIRE
ADM Tronics Reports Third Quarter of Fiscal Year 2023 Results
Via ACCESSWIRE
Novel Therapeutic Technology Developed & Manufactured by ADM Tronics for Origin Life Sciences to Begin Clinical Study on Onychomycosis
Via ACCESSWIRE
ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy Device
Via ACCESSWIRE
ADM Tronics Prepares for Launch of Vet-Sonotron(R) Novel Pain Treatment for Veterinary Market
Via ACCESSWIRE
ADM Tronics Issues Shareholder Update Letter
Via ACCESSWIRE
ADM Tronics Reports Second Quarter of Fiscal Year 2023 Results
Via ACCESSWIRE
ADM Tronics Reports First Quarter of Fiscal Year 2023 Results
Via ACCESSWIRE
ADM Tronics Reports Fiscal Year 2022
From ADM Tronics Unlimited, Inc.
Via AccessWire
Topics Economy
Exposures Product Safety Supply Chain
Aveta.Life Collaborates with ADM Tronics for Regulatory Development
Via NewMediaWire
ADM Tronics Reports Third Quarter of Fiscal Year 2022 Results
From ADM Tronics Unlimited, Inc.
Via AccessWire
Research Study Proves Calmer Canine Veterinary Therapy Device Resolves Separation Anxiety in Dogs
Via NewMediaWire
ADM Tronics Reports Second Quarter of Fiscal Year 2022 Results
From ADM Tronics Unlimited, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ADM Tronics Signs Agreement for Marketing of Vet-Sonotron Veterinary Therapy Device
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ADM Tronics Releases Pre-Production Evaluation Units of New Vet-Sonotron Therapy Device for Veterinary Market
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ADM Tronics Receives First Place in the Category of Electronics at the 2021 Go Global Awards
Via NewMediaWire
Topics Economy Regulatory Compliance
Exposures Economy Legal Regulatory
Intubation Science Selects ADM Tronics to Finalize Development and Manufacture of Breakthrough Intubation System
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ADM Tronics Reports First Quarter of Fiscal Year 2022 Results
From ADM Tronics Unlimited, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Regulatory
ADM Tronics Reports Fiscal Year 2021
From ADM Tronics Unlimited, Inc.
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures Legal Regulatory Supply Chain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.